Cardiovascular Systems, Inc.: FDA filings under this applicant name
FDA lists 28 510(k) clearances under 2 spellings of the applicant name “Cardiovascular Systems, Inc.” (first 2005, latest 2022), plus 1 PMA decision, across 4 product codes in 1 review panel. Median 510(k) review time under this name: 48 days. Since 2017 the median was 60 days, against 100 days for all cleared 510(k)s in the same product codes. Related companies, subsidiaries and acquired businesses that file under other applicant names are counted on their own pages, not here.
510(k) clearances per year
| Year | Clearances | Median review days |
|---|---|---|
| 2012 | 1 | 29 |
| 2013 | 1 | 16 |
| 2014 | 1 | 63 |
| 2015 | 2 | 27 |
| 2016 | 0 | — |
| 2017 | 1 | 85 |
| 2018 | 3 | 61 |
| 2019 | 1 | 112 |
| 2020 | 2 | 50 |
| 2021 | 5 | 30 |
| 2022 | 1 | 47 |
| 2023 | 0 | — |
| 2024 | 0 | — |
| 2025 | 0 | — |
| 2026 | 0 | — |
Review time against the same product codes
Since 2017, 510(k)s cleared under the name Cardiovascular Systems, Inc. took a median 60 days from FDA receipt to decision. All cleared 510(k)s in the same product codes over the same years took a median 100 days.
Top product codes
| Product code | Device | Submissions | 510(k) clearances |
|---|---|---|---|
| MCW | Catheter, Peripheral, Atherectomy | 21 | 21 |
| DQY | Catheter, Percutaneous | 5 | 5 |
| NTE | Temporary Carotid Catheter For Embolic Capture | 2 | 2 |
| MCX | Catheter, Coronary, Atherectomy | 1 | 0 |
Review panels
- Cardiovascular (29)
Most recent Cardiovascular Systems, Inc. 510(k) clearances
| 510(k) | Device | Product code | Decision date | Review days |
|---|---|---|---|---|
| K220109 | DIAMONDBACK 360 Peripheral Orbital Atherectomy System, DIAMONDBACK 360 Peripheral Orbital Atherectomy System, Exchangeable Series, Stealth 360 Peripheral Orbital Atherectomy System | MCW | 2022-03-01 | 47 |
| K212725 | ViperCross Support Catheters | DQY | 2021-09-24 | 28 |
| K210586 | Diamonback 360 Peripheral Orbital Atherectomy System, Diamondback 360 Stealth Orbital Atherectomy system | MCW | 2021-09-14 | 200 |
| K211240 | ViperCross Support Catheters | DQY | 2021-08-26 | 122 |
| K211251 | ViperCath XC Peripheral Exchange Catheter | DQY | 2021-05-26 | 30 |
| K210282 | WIRION Embolic Protection System | NTE | 2021-03-03 | 30 |
| K203008 | DIAMONDBACK 360 Peripheral Orbital Atherectomy System, DIAMONDBACK 360 Peripheral Orbital Atherectomy System, Exchangeable Series, Stealth 360 Peripheral Orbital Atherectomy System | MCW | 2020-11-19 | 49 |
| K200198 | WIRION | NTE | 2020-03-18 | 51 |
| K190634 | Diamondback 360 Peripheral Orbital Atherectomy System, Stealth 360 Peripheral Orbital Atherectomy System | MCW | 2019-07-02 | 112 |
| K183000 | ViperCath XC Peripheral Exchange Catheter | DQY | 2018-12-29 | 60 |
18 earlier clearances. See the full list in Caduvo.
PMA and De Novo decisions
| Number | Pathway | Device | Decision date |
|---|---|---|---|
| P130005 | PMA | DIAMONDBACK 360 CORONARY ORBITAL ATHERECTOMY SYSTEM | 2013-10-21 |
Recalls
17 product recalls in 15 recall events; 1 initiated in the last five years. Most recent: 2021-11-22.
Recalling firms are matched to this applicant name by name only (same normalization), so related entities that recall under another name are not counted. A recall count says nothing about how safe one company's devices are compared with another's.
FDA spellings included
FDA records this applicant under 2 spellings (case, punctuation and legal-suffix variants of one name); this page adds them up. Filings per spelling:
- Cardiovascular Systems, Inc. (27)
- Cardiovascular Systems Incorporated (2)
Other FDA applicant names starting with the same word
FDA records these as separate applicants. Some may belong to the same corporate group and some may not; their filings are not included in the counts above.
- Cardiovascular Imaging Systems, Inc. (19 510(k)s)
- Cardiovascular Diagnostics, Inc. (13 510(k)s)
- Cardiovascular Dynamics, Inc. (11 510(k)s)
- Cardiovascular Devices, Inc. (8 510(k)s)
- Cardiovascular Diagnostic Services (8 510(k)s)
- Cardiovascular Imaging Technologies (4 510(k)s)
- Cardiovascular Imaging Technologies, LLC (3 510(k)s)
- Cardiovascular Research, Inc. (2 510(k)s)
- Cardiovascular Group, Inc. (1 510(k)s)
- Cardiovascular Imaging Solutions , Ltd. (1 510(k)s)
- Cardiovascular Innovations (1 510(k)s)
- Cardiovascular System, Inc. (1 510(k)s)
Frequently asked questions
How many FDA 510(k) clearances are listed under Cardiovascular Systems, Inc.?
FDA lists 28 510(k) clearances under 2 spellings of the applicant name “Cardiovascular Systems, Inc.” (first 2005, latest 2022), plus 1 PMA decision, across 4 product codes in 1 review panel. Filings under other applicant names, such as subsidiaries, are not included.
How long has FDA taken to clear 510(k)s filed by Cardiovascular Systems, Inc.?
The median time from FDA receipt to decision across 510(k)s cleared under the name Cardiovascular Systems, Inc. is 48 days. Since 2017: 60 days, versus 100 days for all cleared 510(k)s in the same product codes.
Which FDA product codes appear under Cardiovascular Systems, Inc.?
The most frequent FDA product codes under this applicant name are MCW (Catheter, Peripheral, Atherectomy, 21); DQY (Catheter, Percutaneous, 5); NTE (Temporary Carotid Catheter For Embolic Capture, 2).
Next steps
- See all 28 Cardiovascular Systems, Inc. clearances with predicates and recalls
- Run predicate analysis for product code MCW, Cardiovascular Systems, Inc.'s most frequent
Compiled by Caduvo from public U.S. government records. Counts cover filings under the applicant names shown on this page only. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA or any other agency, or by the companies named. Not regulatory advice. Report an error in this data. Data and corrections policy.